The kidney used in the latest NYU transplant was procured from a pig with a single genetic edit—the removal of a gene that produces a sugar known as alpha gal. This sugar appears on the surface of pig cells and seems to be responsible for rapid rejection in humans. The pig was engineered by Revivicor, … Read more
Brian Bussard has 25 tiny chips in his brain. They were installed in February 2022 as part of a study testing a wireless device designed to produce rudimentary vision in blind people. Bussard is the first participant. Bussard, who’s 56, lost vision in his left eye at age 17 after his retina detached. The right … Read more
Other than rejection of the organ, one of the most common transplant complications is infection. Doctors have to strike a balance when prescribing immunosuppressive drugs: too low a dose can lead to rejection, while too much can make a patient vulnerable to infection. Immunosuppressants are powerful drugs that can cause a range of side effects, … Read more
In early experiments, Lagasse found that if he injected healthy liver cells into the lymph nodes of mice, the cells would flourish and form a second, smaller liver to take over the functions of the animal’s failing one. The new livers grew up to 70 percent of the size of a native liver. “What happened … Read more
As a designer, what safety considerations did you have to think about with the Neuralink device? The primary safety considerations weren’t so much on the device but on the robot. We had a small role to play, which was to psychologically transform their first-generation robot, which was exposed steel—you could argue it looked pretty ominous—to … Read more
During the course, King was part of a team tasked with identifying research that could be conducted in space with the best potential impact on humankind. Her team landed on the concept of crystallizing drugs in microgravity. There was data stacked up on the International Space Station hinting at the potential to “absolutely revolutionize cancer … Read more
Slayman received his first kidney transplant in 2018 from a human donor. The donor kidney initially functioned well, but Slayman started to go into kidney failure after years of living with diabetes. Diabetes is the leading cause of kidney disease, which can eventually result in kidney failure. He had no choice but to go on … Read more
If you have a dog or cat, chances are you’ve given your pet a flavored chewable tablet for tick prevention at some point. What if you could take a similar pill to protect yourself from getting Lyme disease? Tarsus Pharmaceuticals is developing such a pill for humans—minus the tasty flavoring—that could provide protection against the … Read more
De-extinction startup Colossal Biosciences wants to bring back the woolly mammoth. Well, not the woolly mammoth exactly, but an Asian elephant gene-edited to give it the fuzzy hair and layer of blubber that allowed its close relative to thrive in sub-zero environments. To get to these so-called “functional mammoths,” Colossal’s scientists need to solve a … Read more
Now some key patents have expired, and the US Food and Drug Administration has paved the way for biosimilar versions of insulin—so-called because they’re almost identical to another product already on the market. For a product to be biosimilar, it must be highly similar in structure to the original and work just as well in … Read more
